These mechanisms also might be pertinent at earlier stages, as in the case of adenomatous colon tumors from the Pirc model and in FAP or Lynch Syndrome patients, which harbor predicted MHC neoantigens [42]. The gene discussed is HLA-C; the disease is Lynch syndrome.